Jim Simons Cytosorbents Corp Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cytosorbents Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 134,805 shares of CTSO stock, worth $94,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,805

Previous 116,639 15.57%

Holding current value

$94,363

Previous $149,000 16.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$0.84 - $1.28 $15,259 - $23,252	18,166 Added 15.57%	134,805 $125,000
Q2 2025 Aug 13, 2025	SELL	$0.81 - $1.28 $87,978 - $139,027	-108,615 Reduced 48.22%	116,639 $149,000
Q1 2025 May 14, 2025	BUY	$0.89 - $1.3 $122,138 - $178,404	137,234 Added 155.91%	225,254 $225,000
Q4 2024 Feb 13, 2025	BUY	$0.74 - $1.35 $6,216 - $11,340	8,400 Added 10.55%	88,020 $79,000
Q3 2024 Nov 13, 2024	BUY	$0.7 - $1.55 $2,660 - $5,890	3,800 Added 5.01%	79,620 $119,000

Q2 2024 Aug 09, 2024	SELL	$0.7 - $1.01 $2,660 - $3,838	-3,800 Reduced 4.77%	75,820 $53,000
Q1 2024 May 13, 2024	SELL	$0.86 - $1.07 $82,302 - $102,399	-95,700 Reduced 54.59%	79,620 $76,000
Q4 2023 Feb 13, 2024	BUY	$1.08 - $1.94 $60,717 - $109,066	56,220 Added 47.2%	175,320 $195,000
Q3 2023 Nov 14, 2023	BUY	$1.86 - $4.03 $372 - $806	200 Added 0.17%	119,100 $224,000
Q2 2023 Aug 11, 2023	BUY	$2.37 - $3.65 $711 - $1,095	300 Added 0.25%	118,900 $427,000
Q1 2023 May 12, 2023	BUY	$1.79 - $4.17 $358 - $834	200 Added 0.17%	118,600 $400,000
Q4 2022 Feb 13, 2023	SELL	$1.03 - $2.03 $81,777 - $161,173	-79,396 Reduced 40.14%	118,400 $184,000
Q3 2022 Nov 14, 2022	BUY	$1.2 - $2.46 $69,211 - $141,882	57,676 Added 41.16%	197,796 $269,000
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.22 $97,187 - $177,808	55,220 Added 65.04%	140,120 $307,000
Q1 2022 May 13, 2022	BUY	$2.88 - $4.23 $244,512 - $359,127	84,900 New	84,900 $271,000
Q3 2021 Nov 12, 2021	SELL	$7.0 - $9.71 $980,700 - $1.36 Million	-140,100 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $301,245 - $375,858	-39,900 Reduced 22.17%	140,100 $1.06 Million
Q1 2021 May 13, 2021	BUY	$8.23 - $11.48 $879,787 - $1.23 Million	106,900 Added 146.24%	180,000 $1.56 Million
Q4 2020 Feb 10, 2021	SELL	$7.65 - $8.98 $175,185 - $205,642	-22,900 Reduced 23.85%	73,100 $583,000
Q3 2020 Nov 13, 2020	BUY	$7.37 - $11.54 $707,520 - $1.11 Million	96,000 New	96,000 $766,000
Q2 2019 Aug 12, 2019	SELL	$5.92 - $7.78 $229,696 - $301,864	-38,800 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$6.82 - $8.56 $565,378 - $709,624	-82,900 Reduced 68.12%	38,800 $294,000
Q4 2018 Feb 13, 2019	BUY	$7.05 - $12.64 $857,985 - $1.54 Million	121,700 New	121,700 $983,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $30.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account